Michael John Annable
Corporate Officer/Principal bei Lab 21 Ltd.
Profil
Michael John Annable is currently the Commercial Director at Lab 21 Ltd.
He previously worked as the Sales Director-UK Division at MWG-Biotech AG and as the Director at Myconostica Ltd.
Aktive Positionen von Michael John Annable
| Unternehmen | Position | Beginn |
|---|---|---|
Lab 21 Ltd.
 Lab 21 Ltd. Medical/Nursing ServicesHealth Services Lab 21 Ltd. operates as a healthcare diagnostics company. It specializes in providing patients, doctors, hospitals ,and healthcare providers with diagnostic information for disease identification, disease predisposition, and personalized medicine, to help in managing health problems. It also offers diagnostic products and services and supports blood bank screening, medical diagnostics, and drug discovery. The company was founded in April 2005 by Berwyn E. Clarke and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 01.01.2008 |
Ehemalige bekannte Positionen von Michael John Annable
| Unternehmen | Position | Ende |
|---|---|---|
Myconostica Ltd.
 Myconostica Ltd. Electronic Equipment/InstrumentsElectronic Technology Myconostica Ltd. developed molecular diagnostic fungal testing kits. The company was founded in February 2006 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - |
MWG-Biotech AG
 MWG-Biotech AG Miscellaneous Commercial ServicesCommercial Services MWG-Biotech AG engaged in development and research of synthetic DNA. The company was founded in 1990 and was headquartered in Ebersberg, Germany. | Vertrieb & Marketing | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Lab 21 Ltd.
Lab 21 Ltd. Medical/Nursing ServicesHealth Services Lab 21 Ltd. operates as a healthcare diagnostics company. It specializes in providing patients, doctors, hospitals ,and healthcare providers with diagnostic information for disease identification, disease predisposition, and personalized medicine, to help in managing health problems. It also offers diagnostic products and services and supports blood bank screening, medical diagnostics, and drug discovery. The company was founded in April 2005 by Berwyn E. Clarke and is headquartered in Cambridge, the United Kingdom. | Health Services |
MWG-Biotech AG
MWG-Biotech AG Miscellaneous Commercial ServicesCommercial Services MWG-Biotech AG engaged in development and research of synthetic DNA. The company was founded in 1990 and was headquartered in Ebersberg, Germany. | Commercial Services |
Myconostica Ltd.
Myconostica Ltd. Electronic Equipment/InstrumentsElectronic Technology Myconostica Ltd. developed molecular diagnostic fungal testing kits. The company was founded in February 2006 and is headquartered in Cambridge, the United Kingdom. | Electronic Technology |
